| Literature DB >> 33498338 |
Vittoria Cammisotto1, Cristina Nocella2, Simona Bartimoccia2, Valerio Sanguigni3,4, Davide Francomano3, Sebastiano Sciarretta5,6, Daniele Pastori2, Mariangela Peruzzi5,7, Elena Cavarretta5,7, Alessandra D'Amico8, Valentina Castellani2, Giacomo Frati5,6, Roberto Carnevale5,7, SMiLe Group9.
Abstract
Oxidative stress may be defined as an imbalance between reactive oxygen species (ROS) and the antioxidant system to counteract or detoxify these potentially damaging molecules. This phenomenon is a common feature of many human disorders, such as cardiovascular disease. Many of the risk factors, including smoking, hypertension, hypercholesterolemia, diabetes, and obesity, are associated with an increased risk of developing cardiovascular disease, involving an elevated oxidative stress burden (either due to enhanced ROS production or decreased antioxidant protection). There are many therapeutic options to treat oxidative stress-associated cardiovascular diseases. Numerous studies have focused on the utility of antioxidant supplementation. However, whether antioxidant supplementation has any preventive and/or therapeutic value in cardiovascular pathology is still a matter of debate. In this review, we provide a detailed description of oxidative stress biomarkers in several cardiovascular risk factors. We also discuss the clinical implications of the supplementation with several classes of antioxidants, and their potential role for protecting against cardiovascular risk factors.Entities:
Keywords: antioxidants; biomarkers; cardiovascular disease; oxidative stress; risk factors; supplementation
Year: 2021 PMID: 33498338 DOI: 10.3390/antiox10020146
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921